VR Logo

Lupin Ltd. download report


Healthcare | Drugs & Pharma

Lupin Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2020 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2019 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2018 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2017 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2016 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2015 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2014 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2013 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2012 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2011 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2010 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2009 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2008 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2007 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2006 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2005 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2004 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2003 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2002 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2001 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
2000 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
1999 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
1998 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes
1997 Lupin Ltd. Annual Report Lupin Ltd. chairman speech Lupin Ltd. director's report Lupin Ltd. management discussion Lupin Ltd. corporate governance Lupin Ltd. auditor's report Lupin Ltd. account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Gupta

Group: Lupin

Listing: BSE: 500257, NSE: LUPIN

Country: India

Headquarters: Mumbai, Maharashtra

Website: www.lupin.com

Key Facts

Market cap: ₹28,634.55 Cr

Revenue (TTM): ₹16,405.48 Cr

Earnings (TTM): ₹-1,528.04 Cr

Cash: ₹1,920.53 Cr

Total Debt: ₹4,782.98 Cr

Promoters' ownership: 46.78%

Liquidity: High

52 Week range: ₹583.00 - 1,191.55

Face value: ₹2.00

Shares outstanding: 45,45,52,687

10 Years Aggregate:

  • CFO: ₹16,986.86 Cr
  • EBITDA: ₹29,373.14 Cr
  • Net Profit: ₹13,182.30 Cr

Stock Performance

Time Period Lupin S&P BSE Healthcare S&P BSE Mid Cap
YTD-33.80-17.32-12.68
1 month1.76-4.56-2.88
3 months-15.66-10.61-8.37
1 Year-45.48-12.90-2.81
3 Years-4.0619.5314.24
5 Years-9.909.108.38
10 Years1.7812.4413.75
As on 24-Jun-2022
Year Lupin S&P BSE Mid Cap S&P BSE Healthcare
2021-5.0139.1820.87
202026.6719.8761.45
2019-9.27-3.05-3.55
2018-4.41-13.31-5.89
2017-40.4848.130.49
2016-19.427.97-12.88
201528.557.4315.06